The possibility of a direct effect of SARS-CoV-2 effect on the calcium-vitamin D-parathyroid hormone axis cannot be ruled out, requiring large-scale prospective studies to clarify the mechanisms responsible for hypocalcemia in COVID-19. This evidence concerns the gene PTH and COVID-19.